Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Imidazole SCHEMBL1585849 | 1.00 | — | — | |
| Imidazole SCHEMBL28744226 | 0.96 | ALDH1A1 (1.00) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL1331382 | 0.96 | — | — | |
| Imidazole SCHEMBL19028065 | 0.96 | ALDH1A1 (1.00) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL897 | 0.96 | — | — | |
| Imidazole SCHEMBL30382963 | 0.96 | — | — | |
| Imidazole SCHEMBL2684565 | 0.96 | ALDH1A1 (1.00) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL1331920 | 0.96 | — | — | |
| Imidazole SCHEMBL2635292 | 0.96 | — | — | |
| Imidazole SCHEMBL2298774 | 0.94 | ALDH1A1 (0.81) | ALDH1A1FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12566113-B2 | Reversible fixing reagents and methods of use thereof | 10X GENOMICS, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| CN-119432211-A | Quaternized bisimidazolyl carbon nanotube modified polyurethane coating and preparation method thereof | 湖北省北巷南茂科技有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-20220334031-A1 | REVERSIBLE FIXING REAGENTS AND METHODS OF USE THEREOF | 10X GENOMICS, INC. (US) | 2022-10-20 | — | — | US | disclosed |
| CN-108513574-A | N-sulfonylated pyrazolo [3,4-b ] pyridine-6-carboxamides and methods of use | 艾伯维公司 | 2018-09-07 | — | — | CN | disclosed |
| CN-107848962-A | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | 杏林制药株式会社 | 2018-03-27 | — | — | CN | disclosed |
| US-20160313356-A1 | METHODS AND KITS FOR DETECTING FUNGAL INFECTION | SEMOREX INC. (US) | 2016-10-27 | — | — | US | disclosed |
| CN-103534258-B | Tyrosine kinase inhibitor | 普林斯匹亚生物制药公司 | 2016-09-14 | — | — | CN | disclosed |
| US-9383373-B2 | Methods for detecting fungal infection | SEMOREX INC. (US) | 2016-07-05 | — | — | US | disclosed |
| EP-1955069-B1 | METHODS AND KITS FOR DETECTING FUNGAL INFECTION | SEMOREX INC (US) | 2015-03-18 | — | — | EP | disclosed |
| US-20090111129-A1 | Methods and Kits for Detecting Fungal Infection | SEMOREX INC. (US) | 2009-04-30 | — | — | US | disclosed |
| EP-1955069-A2 | METHODS AND KITS FOR DETECTING FUNGAL INFECTION | Semorex Inc. (US) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007057891-A2 | METHODS AND KITS FOR DETECTING FUNGAL INFECTION | SEMOREX INC. (US) | 2007-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12566113-B2 | Reversible fixing reagents and methods of use thereof | SMCHD1, H1-10, FLT3 | ALDH1A1 117/4885FKBP5 1872/4885 |
| US-20220334031-A1 | REVERSIBLE FIXING REAGENTS AND METHODS OF USE THEREOF | PTMS, FGB, CPSF1 | ALDH1A1 4091/4885FKBP5 1122/4885 |
| US-20090111129-A1 | Methods and Kits for Detecting Fungal Infection | ERG28, CYP51A1, HSD17B11 | ALDH1A1 831/4885FKBP5 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.